Appili Therapeutics Inc (PK) (APLIF)
USOTC
The current APLIF market cap is 3.14M. The company's latest EPS is CAD -0.0312 and P/E is -0.96.
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 886k | 1.29M | 2.45M | 472k | 6.71M |
Operating Income | -5.4M | -14.37M | -23.56M | -7.78M | -2.16M |
Net Income | -5.42M | -14.33M | -25.12M | -9.24M | -3.78M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 11.17M | 18.32M | 8.28M | 3.13M | 1.49M |
Total Liabilities | 2.33M | 5.56M | 11.55M | 10.53M | 12.42M |
Total Equity | 8.85M | 12.75M | -3.27M | -7.4M | -10.93M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -4.26M | -11.45M | -19.08M | -10.1M | -2.46M |
Investing | -1,000 | -4.99M | 5.06M | -3k | -29k |
Financing | 9.36M | 17.02M | 9.56M | 5.91M | 122k |
Market Cap | 3.14M |
Price to Earnings Ratio | -0.96 |
Price to Sales Ratio | 0.54 |
Price to Cash Ratio | 37.5 |
Price to Book Ratio | -0.33 |
Dividend Yield | - |
Shares Outstanding | 121.27M |
Average Volume (1 week) | 367.02k |
Average Volume (1 Month) | 100.04k |
52 Week Change | -44.30% |
52 Week High | 0.069 |
52 Week Low | 0.0162 |
Spread (Intraday) | 0.01 (41.56%) |
Company Name | Appili Therapeutics Inc (PK) |
Address |
21-1344 summer street halifax, nova scotia B3H 0A8 |
Website | https://www.appilitherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.